Pharmacological and molecular targets in the search for novel antipsychotics.

The recent enthusiasm among clinicians for the so-called "atypical antipsychotics" has both improved treatment for schizophrenic patients and provided a welcome stimulus for basic research on antipsychotic mechanisms. Even the newer drugs have shortcomings, and research is underway aimed at identify